SURAKSHA DIAGNOSTIC LTD Fair Value
SURAKSHA · Healthcare · Current price ₹340.2
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹48 | 14% ROE fading to 13% over ~3 yrs, on ₹47 book |
| Relative P/E | ₹400 | EPS × 64.7 peer-median P/E |
| Graham floor | ₹81 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹350 | Street consensus 12-month target price |
Is SURAKSHA DIAGNOSTIC LTD undervalued?
DocStoX estimates the fair value of SURAKSHA DIAGNOSTIC LTD at ₹188 per share, versus the current market price of ₹340. That puts the stock about -44.8% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹48), Relative P/E (₹400), Graham floor (₹81), Analyst target (₹350). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹48 (bear) to ₹188 (base) to ₹400 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on SURAKSHA DIAGNOSTIC LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.